Sun Pharma Advanced Research Com share price
You have to be logged in to add this to Watchlist.- ₹153.85(0.79%)April 23, 2025 15:53:04 PM IST
- NSE
- BSE
- Vol : 875.05K (NSE + BSE)Last 20 day avg : 3.22 M
Sun Pharma Advanced Research Com is trading 0.79% upper at Rs 153.85 as compared to its last closing price. Sun Pharma Advanced Research Com has been trading in the price range of 155.65 & 150.70. Sun Pharma Advanced Research Com has given -23.79% in this year & 6.41% in the last 5 days. The company posted a net profit of -79.51 Crores in its last quarter.Listed peers of Sun Pharma Advanced Research Com include Icra (-0.26%), Quess Corp (-0.64%), Sun Pharma Advanced Research Com (0.79%).The Mutual Fund holding in Sun Pharma Advanced Research Com was at 1.01% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Sun Pharma Advanced Research Com was at 1.45% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 23, 2025, 10:54 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values39.44The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.62Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.49The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable
The company's revenue grew in December quarter by 7.58% from Rs 14.91 crore to Rs 13.86 crore, year-on-year- The company has reduced its December quarter loss by 20.21% from Rs 99.65 crore to Rs 79.51 crore, year-on-year
- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 159.25
- R2
- 170.50
- R3
- 184.10
- S1
- 134.40
- S2
- 120.80
- S3
- 109.55
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Icra | Neutral | 5,760.50 | -0.26 | 5,559.60 | 36.11 | 5.57 | 0.71 | 0.88 |
| Quess Corp | Bearish | 359.05 | -0.64 | 5,348.03 | 16.85 | 1.83 | 2.90 | 11.70 |
| Sun Pharma Advanced Research Com | Neutral | 153.85 | 0.79 | 4,987.78 | - | 39.44 | - | 8.48 |
| Axiscades Technologies | Neutral | 828.60 | -2.71 | 3,467.19 | 105.75 | 6.23 | - | 29.07 |
| Care Ratings | Bullish | 1,196.00 | -1.71 | 3,587.72 | 35.22 | 4.94 | 1.52 | 2.39 |
- Promoter(s) holds a high stake in the company at 65.67%
- FIIs are invested in this company
- FIIs holding has decreased by 0.78 percentage points from previous quarter
- Mutual Funds holding has increased by 0.50 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-10 | Quarterly Results |
| 2024-11-04 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
| 2024-05-24 | Audited Results |
| 2024-02-05 | Quarterly Results |
- IndustryBusiness Services
- ISININE232I01014
- BSE Code532872
- NSE CodeSPARC
Sun Pharma Advanced Research Com is trading at 153.85 as on Wed Apr 23 2025 10:23:04. This is 0.79% upper as compared to its previous closing price of 152.65.
The market capitalization of Sun Pharma Advanced Research Com is 4987.78 Cr as on Wed Apr 23 2025 10:23:04.
The 52 wk high for Sun Pharma Advanced Research Com is 317.00 whereas the 52 wk low is 109.20
Sun Pharma Advanced Research Com can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 28.79
- Dividend Yield: 0.00%
- D/E ratio: -
Sun Pharma Advanced Research Com reported a net profit of -387.21 Cr in 2024.
The Mutual Fund Shareholding was 1.01% at the end of 31 Mar 2025.